BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9140988)

  • 21. Lack of haemodialysis-associated amyloidosis.
    Zingraff J; Bardin T; Noël LH; Drüeke T
    Lancet; 1991 Oct; 338(8774):1089. PubMed ID: 1681397
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta-2-microglobulin amyloidosis and renal bone disease.
    Drüeke TB
    Miner Electrolyte Metab; 1991; 17(4):261-72. PubMed ID: 1813789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging of dialysis-related amyloid (AB-amyloid) deposits with 131I-beta 2-microglobulin.
    Floege J; Burchert W; Brandis A; Gielow P; Nonnast-Daniel B; Spindler E; Hundeshagen H; Shaldon S; Koch KM
    Kidney Int; 1990 Dec; 38(6):1169-76. PubMed ID: 2074658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dialysis amyloidosis: clinical aspects and therapeutic approach.
    Brancaccio D; Cozzolino M; Gallieni M
    Nephrol Dial Transplant; 1996; 11 Suppl 3():102-5. PubMed ID: 8840323
    [No Abstract]   [Full Text] [Related]  

  • 25. Dialysis-related amyloidosis after renal transplantation.
    Campistol JM
    Semin Dial; 2001; 14(2):99-102. PubMed ID: 11264775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pathogenesis of dialysis-related amyloidosis: what's new?
    Zhang X; Hou F
    Chin Med J (Engl); 1999 Dec; 112(12):1059-62. PubMed ID: 11721438
    [No Abstract]   [Full Text] [Related]  

  • 27. C1Q complexes with beta-2-microglobulin and amyloid P-component in sera of patients with dialysis-associated amyloidosis.
    Hasegawa M; Kawashima S; Shikano M; Kojima K; Yanai T; Hassegawa H; Tomita M; Murakami K; Kawamura N; Katsumata H
    Nephron; 1995; 69(4):380-3. PubMed ID: 7777100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dialysis amyloidosis.
    Lancet; 1991 Aug; 338(8763):349-50. PubMed ID: 1677703
    [No Abstract]   [Full Text] [Related]  

  • 29. Dialysis-related beta-2-microglobulin amyloidosis after long-term dialysis, and the effect of renal transplantation and cyclosporin therapy.
    Goldsmith DJ; Covic A; Sambrook P; Ackrill P
    Am J Med; 1996 May; 100(5):587-8. PubMed ID: 8644776
    [No Abstract]   [Full Text] [Related]  

  • 30. Dialysis-related amyloidosis and high-flux membranes.
    Floege J; Smeby L
    Contrib Nephrol; 1992; 96():124-37. PubMed ID: 1740047
    [No Abstract]   [Full Text] [Related]  

  • 31. Scintigraphic methods to detect beta2-microglobulin associated amyloidosis (Abeta2-microglobulin amyloidosis).
    Floege J; Schäffer J; Koch KM
    Nephrol Dial Transplant; 2001; 16 Suppl 4():12-6. PubMed ID: 11402091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum amyloid P component: a predictor of clinical beta 2-microglobulin amyloidosis.
    Spiegel DM; Sprague SM
    Am J Kidney Dis; 1992 May; 19(5):427-32. PubMed ID: 1585929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Historical background and clinical treatment of dialysis-related amyloidosis.
    Yamamoto S; Gejyo F
    Biochim Biophys Acta; 2005 Nov; 1753(1):4-10. PubMed ID: 16226497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, radiological and serum amyloid P component scintigraphic features of beta2-microglobulin amyloidosis associated with continuous ambulatory peritoneal dialysis.
    Tan SY; Baillod R; Brown E; Farrington K; Soper C; Percy M; Clutterbuck E; Madhoo S; Pepys MB; Hawkins PN
    Nephrol Dial Transplant; 1999 Jun; 14(6):1467-71. PubMed ID: 10383009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma kinetics of 125I-labelled amyloid P component in beta 2M amyloidosis: a possible approach to quantitate disease activity.
    Zingraff J; Caillat-Vigneron N; Ureña P; Gagné ER; Bererhi L; Moretti JL; Bardin T; Drüeke TB
    Nephrol Dial Transplant; 1995; 10(2):223-9. PubMed ID: 7753457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dialysis amyloidosis: beta-2-microglobulin in the context of other amyloidogenic proteins.
    Gorevic PD; Munoz P
    Blood Purif; 1988; 6(2):132-44. PubMed ID: 3293617
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
    Gejyo F; Homma N; Arakawa M
    Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dialysis amyloidosis.
    van Ypersele de Strihou C; Honhon B; Vandenbroucke JM; Huaux JP; Noël H; Maldague B
    Adv Nephrol Necker Hosp; 1988; 17():401-21. PubMed ID: 3124550
    [No Abstract]   [Full Text] [Related]  

  • 39. Specific imaging of dialysis-related amyloid deposits using 131I-beta-2-microglobulin.
    Floege J; Nonnast-Daniel B; Gielow P; Brandis A; Spindler E; Hundeshagen H; Koch KM; Shaldon S
    Nephron; 1989; 51(3):444-7. PubMed ID: 2645537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-2-microglobulin-associated amyloidosis.
    Floege J; Ehlerding G
    Nephron; 1996; 72(1):9-26. PubMed ID: 8903856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.